Equities

Biolife Sciences Inc

BLFE:PNK

Biolife Sciences Inc

Actions
  • Price (USD)0.000001
  • Today's Change0.00 / 0.00%
  • Shares traded1.00k
  • 1 Year change-99.50%
  • Beta--
Data delayed at least 15 minutes, as of Jun 11 2024 14:30 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

BioLife Sciences Inc. is a commercialization accelerator, licensor, and disruptive technologies for the healthcare, beauty, and food and beverage industry sectors. The Company’s core business develops, licenses and distributes antimicrobial products and disruptive technology. Its solutions include Antimicrobial Copper Air Filters, Copper-Infused Textiles and Copper Infused Fabric Pots. The Company's BioLife antimicrobial copper fabric filter acts as a layer of protection by trapping in bacteria and releasing clean air. BioLife Antimicrobial Copper-Infused Textiles kill viruses and bacteria on contact through preventative clothing and textiles designed to inhibit virus and bacteria reproduction and cross contamination before it starts. Its BioLife Copper Infused Fabric Pots provides plants a healthier home. The copper infusion allows the plants that grow in the pots with additional protections from harmful microbes which can harm plants.

  • Revenue in USD (TTM)0.00
  • Net income in USD-202.41k
  • Incorporated2000
  • Employees565.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Biolife Sciences Inc0.00-202.41k3.18k565.00---------1.56-1.560.00-0.21820.00-------15,392.40-----------------1.60-----100.00--63.96------
Data as of Jun 11 2024. Currency figures normalised to Biolife Sciences Inc's reporting currency: US Dollar USD

Institutional shareholders

0.00%Per cent of shares held by top holders
HolderShares% Held
MML Investors Services LLCas of 31 Mar 20241.00k0.00%
Wetzel Investment Advisors, Inc.as of 31 Mar 2024337.000.00%
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.